Britain grants first licence for badger cull
Tuberculosis vaccine passes phase I trial
(PhysOrg.com) -- The currently available tuberculosis vaccine BCG is over 90 years old – and its effectiveness is declining. An increasing number of mycobacterial strains are emerging, against which the ...
Mar 24, 2011
not rated yet
0
Blame the environment: Why vaccines may be ineffective for some people
A new discovery may explain why a tuberculosis vaccine is not as effective for some people as anticipated, and potentially explains why other vaccines do not work as well for some as they do for others. In a research report ...
Dec 01, 2010
not rated yet
0
First TB vaccine booster unveiled by Seattle scientists
Seattle scientists have developed a tuberculosis vaccine that may boost the effectiveness of the only existing vaccine, extending immunity against the disease.
Oct 14, 2010
1 / 5 (1)
0
New TB vaccine enters clinical testing
At an international gathering of TB vaccine researchers in Tallinn today, the Aeras Global TB Vaccine Foundation announced it will initiate a clinical trial of an investigational live recombinant tuberculosis vaccine to be ...
Sep 23, 2010
5 / 5 (1)
0
Aeras and Crucell announce Phase II clinical trial start in Kenya
Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell ...
Sep 22, 2010
not rated yet
0
New TB booster shows promise
A booster shot appears to improve tuberculosis (TB) resistance in previously vaccinated adults, according to new research in South Africa.
Mar 16, 2010
not rated yet
0
Gates makes $10 billion vaccines pledge
(AP) -- The Bill and Melinda Gates Foundation will donate $10 billion over the next decade to research new vaccines and bring them to the world's poorest countries, the Microsoft co-founder and his wife said ...
Jan 29, 2010
5 / 5 (1)
0
Vaccines on horizon for AIDS, Alzheimer's, herpes
(AP) -- Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working ...
Nov 17, 2009
3.8 / 5 (4)
1
Drug industry, nonprofits join forces to fight world's neglected diseases
Emerging and re-emerging plagues: Is there a rising danger?
As a result of dominant media coverage of new epidemic threats such as swine influenza, other infection risks receive less public attention than they deserve.
Sep 16, 2009
not rated yet
0
WHO paper: TB vaccine could kill babies with HIV
(AP) -- The World Health Organization says a study has shown that babies with HIV could die if given a standard tuberculosis vaccine.
Jul 01, 2009
5 / 5 (1)
0
TB vaccine gets its groove back
A team of Vanderbilt University Medical Center investigators has cracked one of clinical medicine's enduring mysteries - what happened to the tuberculosis vaccine. The once-effective vaccine no longer prevents the bacterial ...
May 19, 2009
4 / 5 (4)
2
TB vaccine enters new clinical trials
(PhysOrg.com) -- The world’s leading candidate for a tuberculosis vaccine, developed at the University of Oxford, is to enter Phase IIb proof-of-concept clinical trials, making it the first TB candidate ...
Apr 23, 2009
1 / 5 (1)
0
TB breakthrough could lead to stronger vaccine
A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report scientists at The University ...
Mar 03, 2009
3.7 / 5 (3)
1
